PHSE
Pharmhouse Corp
0.0127$
+32.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 100.0% | 2.2% | 58.5% | 18.5% | 51.4% | 39.6% | 7.6% | 2.4% | 16.9% | 20.7% | 7.1% | |
| – | 100.0% | 2.2% | 58.5% | 18.5% | 51.4% | 39.6% | 7.6% | 0.5% | 0.4% | 0.1% | 0.1% | |
| – | 100.0% | 2.2% | 58.5% | 18.5% | 51.4% | 39.6% | 7.6% | 0.5% | 0.4% | 0.1% | 0.1% | |
| – | – | – | – | – | – | – | – | 1.1% | 0.5% | 0.4% | 0.5% | |
| – | – | – | – | – | – | – | – | 0.8% | 0.2% | 0.1% | 0.1% | |
| – | – | – | – | – | – | – | – | – | 39.8% | 38.1% | 44.7% | |
| – | – | 97.8% | 41.5% | 81.5% | 41.8% | 48.3% | 71.9% | – | 10.8% | 10.3% | 12.0% | |
| – | 293.3% | 546.5% | 193.9% | 247.4% | 240.5% | 298.5% | 666.5% | 9.9% | 13.3% | 13.0% | 13.8% | |
| – | 293.3% | 546.5% | 193.9% | 247.4% | 240.5% | 298.5% | 666.5% | 9.9% | 13.0% | 12.7% | 13.5% | |
| – | 286.0% | 523.7% | 185.7% | 226.6% | 199.3% | 230.1% | 324.6% | 7.7% | 7.8% | 8.0% | 8.4% | |
| – | – | – | – | – | – | – | – | 0.8% | 1.5% | 2.5% | 3.7% | |
| – | -193.3% | -446.5% | -93.9% | -147.4% | -140.5% | -198.5% | -566.5% | 90.1% | 86.7% | 87.0% | 86.2% | |
| – | -10,065.5% | -14,470.4% | -2,674.5% | -3,290.6% | -1,849.6% | -2,171.7% | -3,601.2% | -75.3% | -39.7% | -42.2% | -67.9% | |
| – | 169,859.8% | 966,644.6% | 179,192.4% | 219,261.6% | 119,222.3% | 137,645.7% | 207,224.3% | 7,107.2% | 2,539.9% | 3,501.5% | 4,239.2% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.